Analyst: Easy Money Was Made Before There Was a Vaccine on the Horizon

Katherine Ross

There was a lot of vaccine news this morning. 

There’s some good news from Sanofi and GlaxoSmithKline--which have teamed up on a vaccine candidate together--the two announced that it’s begun a combined Phase ½ trial of its experimental COVID-19 vaccine. This comes after promising preclinical results that could put it on track to begin late-stage clinical trials before year-end.

The companies said that they launched human studies of their Covid-19 vaccine candidate at 11 sites across the U.S. The phase-compressed trial, one of several being backed by the U.S. government’s “Operation Warp Speed,” combines the early and middle stages of clinical tests into one.

For the trial, the companies are recruiting 440 adults at 11 trial sites to test out the vaccine. The trials will be randomized, double-blind and placebo-controlled.

The U.S. Centers for Disease Control and Prevention on Wednesday told governors around the U.S. to begin preparing to distribute a potential coronavirus vaccine as soon as Nov. 1. It also provided planning scenarios to help states prepare.

The news has concerned some public health officials that there is a political reason to rush a vaccine in an attempt to distribute it before the election.

And then we have Novovax.

Novovax has early stage clinical trial results show that its vaccine candidate is safe and that it elicits an immune response.

The results were published in a study in the New England Journal of Medicine. The study says that phase 1 clinical trial shows that the candidate “appeared to be safe, and it elicited immune responses that exceeded levels in COVID-19 convalescent serum.”

Following this study, Novavax said it plans to continue with broader phase 2 studies this month to see whether the vaccine protects against COVID-19.

You can follow Katherine Ross on Twitter at @byKatherineRoss.

Read more from Katherine Ross here.

Latest Videos From TheStreet and Jim Cramer:

LIVE WITH JIM CRAMER - WATCH THE REPLAY
Enter your email to register or login. Registration information may be shared with advertising partners in accordance with our Privacy Policy.
Comments (6)
No. 1-6
AlexM5
AlexM5

AlexM5
AlexM5

I've bought like four stocks with companies working towards a vaccine and if none of them end up creating the first vaccine I will be real salty lol

jeehoyun
jeehoyun

lets go novavax!!

JavierFrausto
JavierFrausto

I will take as many vaccine candidates as possible. The more options the better.

kperkins2
kperkins2

Imagine what it's going to look like for whatever company that releases the first successful vaccine! Whewwwwww, big things man

Emmanwo8
Emmanwo8

There is alot of competition to find a vaccine, wonder who will be the last man standing